Holen Sie sich die Stockscreener-App
1.485
1.01%
0.005
Schlusskurs vom Vortag:
$1.48
Offen:
$1.48
24-Stunden-Volumen:
804.78K
Relative Volume:
0.61
Marktkapitalisierung:
$241.86M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
37.12
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
-1.64%
1M Leistung:
+14.12%
6M Leistung:
+130.75%
1J Leistung:
-65.15%
1-Tages-Spanne:
$1.41
$1.52
1-Wochen-Bereich:
$1.41
$1.94
52-Wochen-Spanne:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
Ironwood Pharmaceuticals Inc
Sektor
Telefon
617-621-7722
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Vergleichen Sie IRWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.489 | 240.40M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
143.48 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.14 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.24 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-08-08 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-09 | Eingeleitet | Jefferies | Buy |
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell |
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform |
| 2017-04-07 | Bestätigt | Mizuho | Buy |
| 2017-02-22 | Bestätigt | Barclays | Equal Weight |
| 2016-11-04 | Bestätigt | Mizuho | Buy |
| 2016-10-24 | Bestätigt | Wedbush | Neutral |
| 2016-10-10 | Bestätigt | Mizuho | Buy |
| 2016-09-27 | Bestätigt | WallachBeth | Hold |
Alle ansehen
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance
Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent moveMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Inspire Investing LLC Raises Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
What is the fair value of Ironwood Pharmaceuticals Inc. stock nowJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
Can technical indicators confirm Ironwood Pharmaceuticals Inc.’s reversal - newser.com
Analyzing Ironwood Pharmaceuticals Inc. with risk reward ratio charts2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
News impact scoring models applied to Ironwood Pharmaceuticals Inc.2025 Sector Review & Safe Entry Zone Tips - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explainedJobs Report & Fast Entry Momentum Trade Alerts - newser.com
What does recent volatility data suggest for Ironwood Pharmaceuticals Inc.Rate Cut & Low Drawdown Momentum Trade Ideas - newser.com
Wealth Enhancement Advisory Services LLC Has $96,000 Stake in Ironwood Pharmaceuticals, Inc. $IRWD - Defense World
Is this a good reentry point in Ironwood Pharmaceuticals Inc.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Applying Wyckoff theory to Ironwood Pharmaceuticals Inc. stockTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
Ironwood Pharma Board Member Resigns for New Role - TipRanks
Ironwood Pharmaceuticals director Andrew Dreyfus to resign effective November 1 - Investing.com
What drives Ironwood Pharmaceuticals Inc stock priceEarnings Surprise Analysis & Start Learning With Our Courses - earlytimes.in
Weiss Ratings Reiterates Sell (E+) Rating for Ironwood Pharmaceuticals (NASDAQ:IRWD) - MarketBeat
Published on: 2025-10-09 01:18:56 - newser.com
Ironwood Pharmaceuticals Inc. stock daily chart insights2025 Technical Patterns & AI Driven Price Predictions - newser.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
How risky is Ironwood Pharmaceuticals Inc. stock nowJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Reversal indicators forming on Ironwood Pharmaceuticals Inc. stockWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
What MACD and RSI say about Ironwood Pharmaceuticals Inc.2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceFed Meeting & Capital Efficient Trading Techniques - newser.com
Can Ironwood Pharmaceuticals Inc. hit a new high this monthJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Visualizing Ironwood Pharmaceuticals Inc. stock with heatmapsMarket Growth Report & Daily Market Momentum Tracking - newser.com
Strategies to average down on Ironwood Pharmaceuticals Inc.2025 Key Lessons & Technical Pattern Based Signals - newser.com
Will Ironwood Pharmaceuticals Inc. price bounce be sustainableShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Can momentum traders help lift Ironwood Pharmaceuticals Inc.July 2025 Rallies & High Yield Stock Recommendations - newser.com
Published on: 2025-10-03 03:28:42 - newser.com
Published on: 2025-10-01 06:27:53 - newser.com
IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down - MSN
Ironwood focuses on apraglutide amid workforce cuts - MSN
Is Ironwood Pharmaceuticals Inc. stock reversal real or fakeQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Top chart patterns to watch in Ironwood Pharmaceuticals Inc.Recession Risk & Real-Time Market Trend Scan - newser.com
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ironwood Pharmaceuticals Inc-Aktie (IRWD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
1.02%
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):